These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16500579)

  • 21. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure.
    Jug B; Sebestjen M; Sabovic M; Keber I
    J Card Fail; 2006 Aug; 12(6):446-51. PubMed ID: 16911911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin and aspirin in patients with heart failure and sinus rhythm.
    Homma S; Thompson JL; Pullicino PM; Levin B; Freudenberger RS; Teerlink JR; Ammon SE; Graham S; Sacco RL; Mann DL; Mohr JP; Massie BM; Labovitz AJ; Anker SD; Lok DJ; Ponikowski P; Estol CJ; Lip GY; Di Tullio MR; Sanford AR; Mejia V; Gabriel AP; del Valle ML; Buchsbaum R;
    N Engl J Med; 2012 May; 366(20):1859-69. PubMed ID: 22551105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
    Sorensen SV; Dewilde S; Singer DE; Goldhaber SZ; Monz BU; Plumb JM
    Am Heart J; 2009 Jun; 157(6):1064-73. PubMed ID: 19464418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.
    Gage BF; Cardinalli AB; Owens DK
    Arch Intern Med; 1996 Sep; 156(16):1829-36. PubMed ID: 8790077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
    Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
    Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.
    Katz J; Feldman MA; Bass EB; Lubomski LH; Tielsch JM; Petty BG; Fleisher LA; Schein OD;
    Ophthalmology; 2003 Sep; 110(9):1784-8. PubMed ID: 13129878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
    Pullicino PM; Thompson JL; Sacco RL; Sanford AR; Qian M; Teerlink JR; Haddad H; Diek M; Freudenberger RS; Labovitz AJ; Di Tullio MR; Lok DJ; Ponikowski P; Anker SD; Graham S; Mann DL; Mohr JP; Homma S;
    Cerebrovasc Dis; 2013; 36(1):74-8. PubMed ID: 23921215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.
    Massie BM; Krol WF; Ammon SE; Armstrong PW; Cleland JG; Collins JF; Ezekowitz M; Jafri SM; O'Connor CM; Packer M; Schulman KA; Teo K; Warren S
    J Card Fail; 2004 Apr; 10(2):101-12. PubMed ID: 15101020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke risk, cholesterol and statins.
    Futterman LG; Lemberg L
    Am J Crit Care; 1999 Nov; 8(6):416-9. PubMed ID: 10553183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
    J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.
    Andersen LV; Vestergaard P; Deichgraeber P; Lindholt JS; Mortensen LS; Frost L
    Heart; 2008 Dec; 94(12):1607-13. PubMed ID: 18208828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
    Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
    Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
    Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.